The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Oxytocin receptor antagonists for inhibiting preterm labour
Open accessAbstract
BACKGROUND: Preterm birth, defined as birth before 37 completed weeks, is the single most important cause of perinatal mortality and morbidity in high-income countries. Oxytocin receptor antagonists have been proposed as effective tocolytic agents for women in preterm labour to postpone the birth, with fewer side-effects than other tocolytic agents. OBJECTIVES: To assess the effects on maternal, fetal and neonatal outcomes of tocolysis with oxytocin receptor antagonists for women with preterm labour compared with placebo or no intervention and compared with any other tocolytic agent. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (September 2004), CENTRAL (The Cochrane Library, Issue 3, 2004), MEDLINE (1965 to June 2004), EMBASE (1988 to June 2004). SELECTION CRITERIA: Randomised trials of oxytocin receptor antagonists for tocolysis in the management of women in labour between 20 and 36 weeks' gestation. DATA COLLECTION AND ANALYSIS: Two authors independently evaluated methodological quality and extracted trial data. We sought additional information from trial authors. MAIN RESULTS: Six trials (1695 women) were included. Compared with placebo, atosiban did not reduce incidence of preterm birth or improve neonatal outcome. In one trial (583 infants), atosiban was associated with an increase in infant deaths at 12 months of age compared with placebo (relative risk (RR) 6.15; 95% confidence intervals (CI) 1.39 to 27.22). However, this trial randomised significantly more women to atosiban before 26 weeks' gestation. Use of atosiban resulted in lower infant birthweight (weighted mean difference -138.31 gm; 95% CI -248.76 to -27.86) and more maternal adverse drug reactions (RR 4.02; 95% CI 2.05 to 7.85, 2 trials, 613 women).Compared with betamimetics, atosiban increased the numbers of infants born under 1500 gm (RR 1.96; 95% CI 1.15 to 3.35, 2 trials, 575 infants). Atosiban was associated with fewer maternal drug reactions requiring treatment cessation (RR 0.04; 95% CI 0.02 to 0.11, number needed to treat 6; 95% CI 5 to 7, 4 trials, 1035 women). AUTHORS' CONCLUSIONS: This review failed to demonstrate the superiority of atosiban over betamimetics or placebo in terms of tocolytic efficacy or infant outcomes. The finding of an increase in infant deaths in one placebo controlled trial warrants caution. A recent Cochrane review suggests that calcium channel blockers (mainly nifedipine) are associated with better neonatal outcome and fewer maternal side-effects than betamimetics. However, a randomised comparison of nifedipine with placebo is not available. Further well-designed randomised controlled trials of tocolytic therapy are needed. Such trials should incorporate a placebo arm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rethinking stress in parents of preterm infants: a meta-analysis
Schappin, R., Wijnroks, L., Uniken Venema, M. M. A. T., & Jongmans, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054992 · Cited by 230
Cited by
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., et al. (2013) · Neonatology · doi:10.1159/000349928 · Cited by 550
Iams, J. D., Romero, R., Culhane, J. F., & Goldenberg, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60108-7 · Cited by 500
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis
Haas, D. M., Caldwell, D. M., Kirkpatrick, P., McIntosh, J. J., & Welton, N. J. (2012) · BMJ · doi:10.1136/bmj.e6226 · Cited by 419
Betamimetics for inhibiting preterm labour
Neilson, J. P., West, H. M., & Dowswell, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004352.pub3 · Cited by 300
Prevention of Preterm Delivery
Simhan, H. N., & Caritis, S. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmra050435 · Cited by 292
Metadata
- Authors
- Papatsonis, D., Flenady, V., Cole, S., & Liley, H.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2005-07-20
- Issue
- 3
- Pages
- CD004452-CD004452
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W1900567827
- Cited by
- 246
- References
- 1
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxytocin receptor antagonists for inhibiting preterm labour. https://app.cochat.ai/papers/10.1002/14651858.cd004452.pub2
- The paper
- Papatsonis, D., Flenady, V., Cole, S., & Liley, H. (2005). Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004452.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.